HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kojo S J Elenitoba-Johnson Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

11/2020Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
2/2016API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
10/2007Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma.
4/2004Identification of NPM-ALK interacting proteins by tandem mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kojo S J Elenitoba-Johnson Research Topics

Disease

26Lymphoma (Lymphomas)
01/2023 - 05/2002
23Neoplasms (Cancer)
01/2023 - 07/2002
11Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2020 - 05/2002
11Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015 - 05/2002
8Genetic Translocation (Chromosomal Translocation)
11/2018 - 02/2004
7Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 05/2002
7B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 08/2002
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 05/2002
5Leukemia
08/2014 - 06/2003
4Burkitt Lymphoma (Burkitt's Lymphoma)
01/2023 - 05/2002
4Chromosome Aberrations (Chromosome Abnormalities)
11/2020 - 04/2004
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2020 - 07/2004
3Carcinogenesis
02/2016 - 05/2006
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2016 - 10/2009
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2015 - 07/2004
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2015 - 05/2002
3Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2014 - 07/2009
3Hodgkin Disease (Hodgkin's Disease)
12/2009 - 11/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 05/2002
2Neuroblastoma
11/2010 - 05/2002
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2021
1Multiple Myeloma
01/2020
1Substance-Related Disorders (Drug Abuse)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2017
1Castleman Disease (Castleman's Disease)
03/2017
1Cytokine Release Syndrome
03/2017
1Cytopenia
03/2017
1Anemia
03/2017
1Edema (Dropsy)
03/2017
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2017
1Proteinuria
03/2017
1Thrombocytopenia (Thrombopenia)
03/2017
1Thrombocytosis (Thrombocythemia)
03/2017
1Interstitial Lung Diseases (Interstitial Lung Disease)
03/2017
1Hypoalbuminemia
03/2017
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2015
1Ameloblastoma
11/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
12/2017 - 10/2002
10Anaplastic Lymphoma KinaseIBA
01/2017 - 02/2004
6Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2006
6UbiquitinIBA
01/2020 - 10/2002
5Pyridinolcarbamate (P23)IBA
03/2008 - 02/2004
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2023 - 07/2015
3RNA (Ribonucleic Acid)IBA
01/2023 - 02/2004
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 01/2015
3Ligases (Synthetase)IBA
01/2017 - 10/2002
3Tyrosine (L-Tyrosine)FDA Link
12/2014 - 04/2007
3PhosphoproteinsIBA
05/2014 - 12/2005
3Peptides (Polypeptides)IBA
05/2014 - 11/2005
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2013 - 10/2006
3Protein Isoforms (Isoforms)IBA
08/2013 - 12/2005
3ProteomeIBA
11/2007 - 12/2005
3Complementary DNA (cDNA)IBA
08/2004 - 07/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 11/2010
2ParaffinIBA
01/2023 - 01/2015
2Tumor Biomarkers (Tumor Markers)IBA
11/2021 - 10/2013
2Circulating Tumor DNAIBA
11/2021 - 01/2019
2Messenger RNA (mRNA)IBA
11/2020 - 05/2002
2Phosphotransferases (Kinase)IBA
01/2020 - 12/2014
2Rituximab (Mabthera)FDA Link
12/2017 - 05/2009
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2013 - 04/2005
2p38 Mitogen-Activated Protein KinasesIBA
10/2009 - 08/2004
2p80(NPM-ALK) proteinIBA
08/2009 - 05/2006
2NucleophosminIBA
03/2008 - 05/2006
2Transcription Factors (Transcription Factor)IBA
12/2005 - 07/2004
1Lymphoid Enhancer-Binding Factor 1IBA
01/2023
1Cell-Free Nucleic AcidsIBA
11/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020
1Immunoglobulins (Immunoglobulin)IBA
11/2020
1Antigen Receptors (Antigen Receptor)IBA
11/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Macrophage Colony-Stimulating FactorIBA
01/2020
1ChromatinIBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1obinutuzumabIBA
12/2017
1C-Reactive ProteinIBA
03/2017
1Interleukin-6 (Interleukin 6)IBA
03/2017
1CaspasesIBA
01/2017
1Glycoproteins (Glycoprotein)IBA
01/2017
1Cytokine Receptors (Cytokine Receptor)IBA
01/2017
1prostate apoptosis response-4 proteinIBA
01/2017
1Oncogene Proteins (Oncogene Protein)IBA
02/2016
1Peptide Hydrolases (Proteases)FDA Link
02/2016
1Deubiquitinating EnzymesIBA
07/2015
1Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA
01/2015
1Formaldehyde (Formol)FDA Link
01/2015
1EnzymesIBA
01/2015
1Small Interfering RNA (siRNA)IBA
12/2014
1Mitogen-Activated Protein KinasesIBA
11/2014
1GlycosphingolipidsIBA
05/2014
1Lactic Acid (Lactate)FDA LinkGeneric
08/2013
1Pyruvate KinaseIBA
08/2013
1tau Proteins (tau Protein)IBA
06/2013
1MethyltransferasesIBA
09/2011

Therapy/Procedure

16Therapeutics
01/2023 - 06/2003
2Precision Medicine
01/2018 - 01/2016
1Semiconductors
01/2023
1Aftercare (After-Treatment)
12/2017